1. Home
  2. CGEM vs VPG Comparison

CGEM vs VPG Comparison

Compare CGEM & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • VPG
  • Stock Information
  • Founded
  • CGEM 2016
  • VPG 2009
  • Country
  • CGEM United States
  • VPG United States
  • Employees
  • CGEM N/A
  • VPG N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • VPG Electrical Products
  • Sector
  • CGEM Health Care
  • VPG Technology
  • Exchange
  • CGEM Nasdaq
  • VPG Nasdaq
  • Market Cap
  • CGEM 366.3M
  • VPG 427.5M
  • IPO Year
  • CGEM 2021
  • VPG N/A
  • Fundamental
  • Price
  • CGEM $5.95
  • VPG $31.65
  • Analyst Decision
  • CGEM Strong Buy
  • VPG
  • Analyst Count
  • CGEM 7
  • VPG 0
  • Target Price
  • CGEM $26.00
  • VPG N/A
  • AVG Volume (30 Days)
  • CGEM 789.8K
  • VPG 92.4K
  • Earning Date
  • CGEM 11-06-2025
  • VPG 11-04-2025
  • Dividend Yield
  • CGEM N/A
  • VPG N/A
  • EPS Growth
  • CGEM N/A
  • VPG N/A
  • EPS
  • CGEM N/A
  • VPG N/A
  • Revenue
  • CGEM N/A
  • VPG $295,282,000.00
  • Revenue This Year
  • CGEM N/A
  • VPG N/A
  • Revenue Next Year
  • CGEM N/A
  • VPG $5.40
  • P/E Ratio
  • CGEM N/A
  • VPG N/A
  • Revenue Growth
  • CGEM N/A
  • VPG N/A
  • 52 Week Low
  • CGEM $5.68
  • VPG $18.57
  • 52 Week High
  • CGEM $17.98
  • VPG $33.81
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 39.45
  • VPG 54.78
  • Support Level
  • CGEM $5.68
  • VPG $31.29
  • Resistance Level
  • CGEM $6.13
  • VPG $33.02
  • Average True Range (ATR)
  • CGEM 0.29
  • VPG 1.01
  • MACD
  • CGEM 0.03
  • VPG -0.19
  • Stochastic Oscillator
  • CGEM 28.42
  • VPG 32.92

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

Share on Social Networks: